Avnika Amin
Post Doctoral Fellow
PostDoctoral
Post Doctoral Fellow, Biostatistics and Bioinformatics
Post Doctoral Fellow, Epidemiology
I am a vaccine epidemiologist who has worked across all stages of vaccine development and roll-out: pre-clinical testing, clinical trials, post-licensure evaluation, and vaccine uptake. I have specific experience with infectious disease surveillance data; vaccine monitoring and evaluation; analysis of clinical trials, interventions, and observational vaccine studies; and quantitative data collection.
I research the dynamics between vaccines and infectious disease epidemiology, focusing on how such dynamics may change or bias vaccine effects from clinical trials and observational studies. I specifically work on identifying potential issues for vaccine studies and developing analytic improvements to identify and address such impacts. The long-term goal of this work is to identify subtle but key priorities for data collection in vaccine studies. My recent work includes methodologic issues affecting variation in observed rotavirus vaccine effects and COVID-19 surveillance to monitor vaccine impacts on a national level and identify early signals of changes in vaccine effects.
Contact Information
1518 Clifton Rd
Atlanta , GA
Email: AAMIN23@emory.edu
URL: https://scholar.google.com/citations?user=NvHBNN8AAAAJ&hl=en
Areas of Interest
- Clinical Trials
- Disease Surveillance
- Epidemiology
- Global Health
- Infectious Disease
- Vaccines
Education
- PhD 2021, Emory University
- MSPH 2017, Emory University
Affiliations & Activities
Publications
- Amin AB*, Johnson AG*, Ali AR, Hoots B, Cadwell BL, Arora S, et al, 2022, COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021, Morbidity and Mortality Weekly Report, 41,
- Amin AB, Tate JE, Waller LA, Lash TL, Lopman BA, 2022, Monovalent rotavirus vaccine efficacy against different rotavirus genotypes: a pooled analysis of Phase II and III trial data, Clinical Infectious Diseases, ,
- Dube WC, Kellogg JT, Adams C, Collins MH, Lopman BA, Johnson II TM, Amin AB, Weitz JS, Fridkin SK, 2022, Quantifying Risk for SARS-CoV-2 Infection Among Nursing Home Workers for the 2020-2021 Winter Surge of the COVID-19 Pandemic in Georgia, USA, Journal of the American Medical Directors Association, 23, 942-6e.1
- Amin AB, Lash TL, Tate JE, Waller LA, Wikswo ME, et al, 2022, Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification, Epidemiology, 33, 660-669
- Paz-Bailey G, Sternberg M, Kugeler K, Hoots B, Amin AB, Johnson AG, et al, 2021, Covid-19 rates by time since vaccination during delta variant predominance, NEJM Evidence, 1,
- Cates JC, Amin AB, Tate JE, Lopman BA, Parashar UD, 2021, Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis, The Pediatric Infectious Disease Journal, 40, 1135–1143
- Amin AB, Kellogg JT, Adams C, Dube WC, Collins MH, Lopman BA, Johnson II TM, Weitz J, Fridkin SK, 2021, Risk factors for SARS-CoV-2 seropositivity among nursing home staff, Antimicrobial Stewardship & Healthcare Epidemiology, 1,
- Amin AB, Nunes MC, Madhi SA, Cutland CL, Wairagkar N, Omer SB, 2020, Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa, Vaccine, 38,